Cantel Medical has completed its acquisition of Hu-Friedy, which was first announced in July. Hu-Friedy will be combined with Cantel Medical's Crosstex division.
Ron Saslow, the chairman and CEO of Hu-Friedy, and Ken Serota, president of Hu-Friedy, will lead the combined dental business after the transaction closes.
The acquisition price was $725 million in cash and stock, according to Cantel.